Skip to main content

Name
Edwin Ocran

Tue, 09/24/2019 - 23:04

Thank you Dr. Gerszten for the great presentation and for having a more in-depth discussion about your research with us during the post-round group session. One of the things I found interesting was how metabolomics could potentially predict the development of conditions like cardiovascular disease in individuals who would have otherwise been overlooked based on traditional risk factors and testing such as age, smoking, high blood pressure, and high cholesterol. This is a very promising field and I am eager to see the advancement it brings to clinical care in the near future.

Name
Edwin Ocran

Plain text

  • No HTML tags allowed.
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.